213 related articles for article (PubMed ID: 30201569)
1. Comparative study on disintegration methods for oral film preparations.
Speer I; Steiner D; Thabet Y; Breitkreutz J; Kwade A
Eur J Pharm Biopharm; 2018 Nov; 132():50-61. PubMed ID: 30201569
[TBL] [Abstract][Full Text] [Related]
2. Prolonged drug release properties for orodispersible films by combining hot-melt extrusion and solvent casting methods.
Speer I; Preis M; Breitkreutz J
Eur J Pharm Biopharm; 2018 Aug; 129():66-73. PubMed ID: 29792911
[TBL] [Abstract][Full Text] [Related]
3. Orodispersible films in individualized pharmacotherapy: The development of a formulation for pharmacy preparations.
Visser JC; Woerdenbag HJ; Crediet S; Gerrits E; Lesschen MA; Hinrichs WLJ; Breitkreutz J; Frijlink HW
Int J Pharm; 2015 Jan; 478(1):155-163. PubMed ID: 25448577
[TBL] [Abstract][Full Text] [Related]
4. Key acceptability attributes of orodispersible films.
Scarpa M; Paudel A; Kloprogge F; Hsiao WK; Bresciani M; Gaisford S; Orlu M
Eur J Pharm Biopharm; 2018 Apr; 125():131-140. PubMed ID: 29355687
[TBL] [Abstract][Full Text] [Related]
5. Increased drug load and polymer compatibility of bilayered orodispersible films.
Carolina Visser J; Weggemans OAF; Boosman RJ; Loos KU; Frijlink HW; Woerdenbag HJ
Eur J Pharm Sci; 2017 Sep; 107():183-190. PubMed ID: 28709911
[TBL] [Abstract][Full Text] [Related]
6. Development, In Vitro and In Vivo Evaluation of Racecadotril Orodispersible Films for Pediatric Use.
Wang B; Yang L; Wang B; Luo C; Wang Y; Wang H; Chen F; Xiang X
AAPS PharmSciTech; 2021 Jan; 22(1):15. PubMed ID: 33389269
[TBL] [Abstract][Full Text] [Related]
7. Comparative study on novel test systems to determine disintegration time of orodispersible films.
Preis M; Gronkowsky D; Grytzan D; Breitkreutz J
J Pharm Pharmacol; 2014 Aug; 66(8):1102-11. PubMed ID: 24673551
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Solvent Casting and Spray Casting Method on Compounding of an Orally Disintegrating Film Containing Amlodipine Besylate.
Ruslan MFH; Janakiraman AK; Ming LC; Uddin AH; Sarker ZI; Bin LK
Int J Pharm Compd; 2022; 26(2):155-162. PubMed ID: 35413014
[TBL] [Abstract][Full Text] [Related]
9. Continuous manufacturing and analytical characterization of fixed-dose, multilayer orodispersible films.
Thabet Y; Lunter D; Breitkreutz J
Eur J Pharm Sci; 2018 May; 117():236-244. PubMed ID: 29499348
[TBL] [Abstract][Full Text] [Related]
10. Development and characterization of an orodispersible film containing drug nanoparticles.
Shen BD; Shen CY; Yuan XD; Bai JX; Lv QY; Xu H; Dai L; Yu C; Han J; Yuan HL
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1348-56. PubMed ID: 24103635
[TBL] [Abstract][Full Text] [Related]
11. Effect of polymer, plasticizer and filler on orally disintegrating film.
Liew KB; Tan YT; Peh KK
Drug Dev Ind Pharm; 2014 Jan; 40(1):110-9. PubMed ID: 23311593
[TBL] [Abstract][Full Text] [Related]
12. Hydroxypropyl Methylcellulose Orodispersible Film Containing Desloratadine for Geriatric Use: Formulation and Evaluation.
Al-Oran AYF; Yenilmez E
Antiinflamm Antiallergy Agents Med Chem; 2023; 22(2):79-91. PubMed ID: 37904551
[TBL] [Abstract][Full Text] [Related]
13. Compounding and Characterization of Oral Disintegrating Films Containing Memantine Hydrochloride for Geriatrics.
Rofiq HM; Phang HC; Janakiraman AK; Chew YL; Uddin AH; Sarker ZI; Lee SK; Liew KB
Int J Pharm Compd; 2023; 27(6):512-521. PubMed ID: 38100669
[TBL] [Abstract][Full Text] [Related]
14. Development of orodispersible polymer films with focus on the solid state characterization of crystalline loperamide.
Woertz C; Kleinebudde P
Eur J Pharm Biopharm; 2015 Aug; 94():52-63. PubMed ID: 25976316
[TBL] [Abstract][Full Text] [Related]
15. Development and Characterization of an Orodispersible Film for Vitamin D3 Supplementation.
Cupone IE; Dellera E; Marra F; Giori AM
Molecules; 2020 Dec; 25(24):. PubMed ID: 33322282
[TBL] [Abstract][Full Text] [Related]
16. Orodispersible films and tablets with prednisolone microparticles.
Brniak W; Maślak E; Jachowicz R
Eur J Pharm Sci; 2015 Jul; 75():81-90. PubMed ID: 25889975
[TBL] [Abstract][Full Text] [Related]
17. Efficient production of nanoparticle-loaded orodispersible films by process integration in a stirred media mill.
Steiner D; Finke JH; Kwade A
Int J Pharm; 2016 Sep; 511(2):804-13. PubMed ID: 27477101
[TBL] [Abstract][Full Text] [Related]
18. Development of polymer-bound fast-dissolving metformin buccal film with disintegrants.
Haque SE; Sheela A
Int J Nanomedicine; 2015; 10 Suppl 1(Suppl 1):199-205. PubMed ID: 26491321
[TBL] [Abstract][Full Text] [Related]
19. A novel unit-dose approach for the pharmaceutical compounding of an orodispersible film.
Foo WC; Khong YM; Gokhale R; Chan SY
Int J Pharm; 2018 Mar; 539(1-2):165-174. PubMed ID: 29414124
[TBL] [Abstract][Full Text] [Related]
20. Formulation Optimization and in Vitro Characterization of Orally Disintegrating Films Using a Factorial Design and Mathematical Modeling for Drug Release.
Lee Y; Thapa P; Jeong SH; Woo MH; Choi DH
Chem Pharm Bull (Tokyo); 2017 Feb; 65(2):166-177. PubMed ID: 27904030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
